Dr. Peter Jonathan Frederick, MD

Dr. Frederick practices at Roswell Park Cancer Institute in Los Angeles, California.

Dr. Frederick's NPI, 1558579078, was assigned on May 18, 2007. Dr. Frederick graduated from University at Buffalo School of Medicine in 2003. Dr. Frederick holds New York license 256843.

Dr. Frederick's primary practice is Roswell Park Cancer Institute, at 344 S Hauser Blvd, Los Angeles, CA 90036 in Los Angeles County. The practice phone is (716) 845-2300.

Dr. Frederick's primary practice is Roswell Park Cancer Institute in Los Angeles, California. Dr. Frederick is also affiliated with Roswell Park Comprehensive Cancer Center. The medical group on file is Breast Care of Western New York. Dmand AI also links Dr. Frederick to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Frederick practices. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Frederick's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Frederick is licensed in New York.

CMS data shows 155 Medicare services from Dr. Frederick across 4 procedure codes in 2024, all of them office visits, for 131 Medicare patients. Medicare paid $10,341 for them.

CMS counts 131 Medicare patients who saw Dr. Frederick in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Frederick's median patient age at 69, with 99% women.

In 2024, Dr. Frederick wrote 17 Medicare Part D claims for 11 patients. 100% of them were for generic drugs. They cover 2 drugs, with $9,121 in total drug cost.

Dr. Frederick accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 20 procedures of removal of the uterus by Dr. Frederick, more than 93% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 43 papers to Dr. Frederick, published from 2011 to 2025. 2016 was the busiest year, with 5. The most frequent topics are Antineoplastic Agents, Genital Neoplasms, Female and Ovarian Neoplasms. Dr. Frederick has published most often in Int J Gynecol Cancer. Dr. Frederick's most frequent co-authors are Christina S. Chu, MD, Marta Ann Crispens, MD and David K. Gaffney, MD, PhD.

CMS Open Payments shows 20 general payments to Dr. Frederick from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 60% of the total. Novadaq Technologies Inc. paid the most, $2,592.

Dr. Frederick graduated from University at Buffalo School of Medicine in 2003.